Compare Immunefi (IMU) vs Scallop (SCA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunefi vs Scallop — how do they compare? Immunefi trades at Rp24.67 (market cap Rp27,03M, Rp39,91M 24h volume), while Scallop trades at Rp167.58 (market cap Rp25,18M, Rp11,57M 24h volume). The key difference: Immunefi and Scallop are close in size by market cap, and Immunefi's circulating supply is 873,4M / 10B IMU (9%) versus 163,5M / 250M SCA (66%) for Scallop. Which is the better fit depends on your goals — on Pluang, investors hold Immunefi for 5 Days and Scallop for 13 Days on average.
| IMU | SCA | |
|---|---|---|
Market Cap | Rp27,03M | Rp25,18M |
Volume (24h) | Rp39,91M | Rp11,57M |
Circulating Supply | 873,4M / 10B IMU (9%) | 163,5M / 250M SCA (66%) |
Typical Hold Time | 5 Days | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Immunefi (IMU) currently trades with a market cap of Rp27.03M and a circulating supply of 873.4 million tokens (9% of max supply). The asset shows limited market activity with a short average hold time of 5 days, indicating potential speculative trading patterns. Recent coverage appears to confuse the token with a corporate entity, requiring careful verification of crypto-specific metrics.
Outlook remains cautious due to low circulation rate and potential identity confusion. Key opportunity lies in proper crypto ecosystem positioning, while major risks include liquidity constraints and market misidentification. Investors should verify on-chain metrics and exchange listings before considering exposure.
Scallop (SCA) is trading at Rp168.32 with a market cap of Rp25.17 million, showing bullish technical signals despite bearish moving averages. The token has 66% of its max supply in circulation with an average hold time of 13 days. Recent ETF inclusion by GraniteShares in May 2026 provides institutional exposure, though the news articles reference equity ETFs rather than direct cryptocurrency developments.
Overall outlook is cautiously optimistic with technical strength but limited fundamental catalysts. Key opportunities include institutional ETF exposure and neutral oscillator positioning. Major risks include high RSI_6 at 89.40 (overbought), low market cap vulnerability, and the token's relatively new market presence requiring careful risk management.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Immunefi
Immunefi is a security-focused ecosystem token designed to reward contributions to blockchain safety. It aligns protocols, researchers, and communities through bug bounties, staking, and governance incentives. The ecosystem also integrates AI to enhance threat detection and scale protection as the on-chain economy grows.
Read more on IMU →About Scallop
Scallop is an advanced decentralized finance (DeFi) protocol built on the Sui blockchain. It offers a wide range of financial services, including lending, borrowing, automated market making (AMM), and asset management. Developed by Scallop Labs, which has a team of experts in DeFi, cybersecurity, and fintech, Scallop has attracted support from notable investors such as CMS Holdings, 6th Man Ventures, KuCoin Labs, and Mysten Labs. Additionally, it is the first DeFi project to receive an official grant from the Sui Foundation, highlighting its institutional-grade quality and strong security features.
Read more on SCA →
